MedPath

The Impact of Obesity on Short Stem Total Hip Arthroplasty

Completed
Conditions
THA
Obesity
Interventions
Procedure: Total hip arthroplasty
Registration Number
NCT06430723
Lead Sponsor
Krankenhaus Barmherzige Schwestern Linz
Brief Summary

The purpose of this study is to review the impact of obesity on subsidence and clinical outcome after short stem total hip arthroplasty.

Detailed Description

Short stem total hip arthroplasty (THA) has gained popularity due to its bone-sparing technique, but its outcomes in obese patients remain uncertain.

While studies on the mid-term outcome in a general patient cohort provide excellent results in terms of the clinical and radiological outcome as well as the complication rate of short stem THA, data on its use in obese patients is still rare and not sufficiently conclusive. Some studies have found no evidence of increased subsidence in obese patients, while other studies have shown contrary trends.

In this context, the aim of this study was to investigate the relationship between BMI, postoperative subsidence and clinical outcomes in the setting of short stem THA.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. patients who underwent primary short stem hip arthroplasty with Mathys Optimys short stem between 01.01.2018 and 31.12.2020
  2. availability of preoperative and postoperative radiographs for assessment of subsidence
  3. a minimum BMI of 30kg/m2 for the obese group
  4. a minimum follow-up of 24 months.
Exclusion Criteria
  1. former surgeries of the hip in question
  2. incomplete clinical data
  3. incomplete radiological data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-obeseTotal hip arthroplastyBody mass index \< 30 kg/m2
ObeseTotal hip arthroplastyBody mass index \>= 30 kg/m2
Primary Outcome Measures
NameTimeMethod
Harris Hip Score2 years

Clinical outcome, \[0-100points\]

Subsidence2 years

subsidence of the short stem measured via EBRA (Einzelbild Röntgenanalyse), \[mm\]

Secondary Outcome Measures
NameTimeMethod
surgery time2 years

Surgery time from cut to skin closure, \[minutes\]

Length of stay2 years

Length of postoperative stay in hospital \[days\]

Blood loss2 years

Blood loss calculated according to laboratory test results of hematocrit \[ml\]

Trial Locations

Locations (1)

Ordensklinikum Linz, Barmherzige Schwestern Abteilung Orthopädie

🇦🇹

Linz, Austria

© Copyright 2025. All Rights Reserved by MedPath